SYNLOGIC, INC. Operating Lease, Payments
SYNLOGIC, INC. (SYBX) reported Operating Lease, Payments of $2.40 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2025-03-06
- SYNLOGIC, INC. operating lease, payments for the quarter ending 2019-12-31 was $1.00M.
- SYNLOGIC, INC. operating lease, payments for the quarter ending 2019-09-30 was $1.00M.
- SYNLOGIC, INC. operating lease, payments for the quarter ending 2019-06-30 was $1.00M.
- SYNLOGIC, INC. operating lease, payments for the quarter ending 2019-03-31 was $800.00K.
- SYNLOGIC, INC. operating lease, payments for fiscal 2024 was $2.40M, a 57.14% decline from fiscal 2023.
- SYNLOGIC, INC. operating lease, payments for fiscal 2023 was $5.60M, a 1.82% increase from fiscal 2022.
- SYNLOGIC, INC. operating lease, payments for fiscal 2022 was $5.50M, a 25.00% increase from fiscal 2021.
- SYNLOGIC, INC. operating lease, payments for fiscal 2021 was $4.40M, a 12.82% increase from fiscal 2020.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.40M 10-K · filed 2025-03-06 | |||
| 2023-12-31 | $5.60M 10-K · filed 2025-03-06 | |||
| 2022-12-31 | $5.50M 10-K · filed 2024-03-19 | |||
| 2021-12-31 | $4.40M 10-K · filed 2023-03-29 | |||
| 2020-12-31 | $3.90M 10-K · filed 2022-03-17 | |||
| 2019-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.00M derived: sum of 2 quarters · filed 2021-03-25 | $3.00M derived: sum of 3 quarters · filed 2021-03-25 | $3.70M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.00M 10-Q · filed 2019-11-12 | $2.00M derived: sum of 2 quarters · filed 2019-11-12 | $2.70M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-08 | $1.70M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $800.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |